UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (768) 768
Newsletter (276) 276
Newspaper Article (17) 17
Book Chapter (11) 11
Magazine Article (10) 10
Dissertation (9) 9
Book / eBook (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
galanthamine (1048) 1048
alzheimer's disease (438) 438
science & technology (428) 428
life sciences & biomedicine (386) 386
research (231) 231
humans (209) 209
drug therapy (199) 199
animals (175) 175
analysis (174) 174
galantamine (170) 170
medical research (160) 160
male (155) 155
medicine, experimental (154) 154
pharmacology & pharmacy (147) 147
neurosciences & neurology (145) 145
neurosciences (137) 137
galantamine - pharmacology (116) 116
alzheimer disease - drug therapy (109) 109
universities and colleges (104) 104
care and treatment (103) 103
drugs (101) 101
cholinesterase inhibitors - pharmacology (99) 99
female (97) 97
cholinesterase inhibitors - therapeutic use (88) 88
galantamine - therapeutic use (86) 86
rats (75) 75
chemistry (70) 70
acetylcholine (67) 67
acetylcholinesterase (66) 66
alkaloids (66) 66
physical sciences (66) 66
aged (65) 65
dementia (62) 62
biochemistry & molecular biology (60) 60
neurology (59) 59
donepezil (58) 58
rivastigmine (57) 57
cholinesterase inhibitors (56) 56
pharmaceutical industry (56) 56
alzheimers disease (54) 54
dosage and administration (54) 54
dose-response relationship, drug (51) 51
acetylcholinesterase - metabolism (48) 48
amaryllidaceae (48) 48
psychiatry (48) 48
lycorine (47) 47
clinical neurology (45) 45
galantamine - chemistry (45) 45
treatment outcome (44) 44
enzymes (43) 43
galantamine - administration & dosage (42) 42
nootropic agents - therapeutic use (42) 42
plant sciences (42) 42
clinical trials (41) 41
cholinesterase inhibitors - chemistry (40) 40
health aspects (40) 40
alzheimer’s disease (39) 39
pharmacy (39) 39
cholinesterase inhibitors - administration & dosage (38) 38
physiological aspects (38) 38
middle aged (37) 37
brain (36) 36
chemistry, analytical (36) 36
cognition - drug effects (36) 36
schizophrenia (35) 35
geriatrics & gerontology (34) 34
mice (34) 34
rats, sprague-dawley (34) 34
cognition (33) 33
physical fitness (33) 33
aged, 80 and over (32) 32
amyloid beta-protein (32) 32
chemistry, medicinal (32) 32
adult (31) 31
brain - drug effects (29) 29
cholinesterase inhibitors - adverse effects (29) 29
memantine (29) 29
organic chemistry (29) 29
time factors (29) 29
methyl aspartate (28) 28
usage (28) 28
acetylcholinesterase inhibitors (27) 27
cognitive ability (27) 27
galantamine - adverse effects (27) 27
neurodegenerative diseases (27) 27
pharmacology (27) 27
double-blind method (26) 26
mass spectrometry (26) 26
neurons (26) 26
rats, wistar (26) 26
disease models, animal (25) 25
memory (25) 25
activities of daily living (24) 24
antipsychotic drugs (24) 24
biomedicine (24) 24
cognition disorders - drug therapy (24) 24
acetylcholinesterase inhibitor (23) 23
behavioral sciences (23) 23
development and progression (23) 23
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1076) 1076
Japanese (11) 11
German (7) 7
French (3) 3
Spanish (3) 3
Chinese (2) 2
Korean (2) 2
Portuguese (2) 2
Turkish (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Alzheimer's & dementia, ISSN 1552-5260, 2013, Volume 9, Issue 4, pp. P659 - P660
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 2012, Volume 8, Issue 4, pp. P586 - P586
Journal Article
British journal of pharmacology, ISSN 0007-1188, 10/2008, Volume 155, Issue 3, pp. 434 - 440
Journal Article
Current drug discovery technologies, ISSN 1570-1638, 12/2015, Volume 12, Issue 4, pp. 214 - 217
Alzheimer's disease (AD) is supposed to stanch from inappropriate waving in the brain sections related to memory and perception. The incidence of AD in... 
ACS-40 | Alzheimer disease | Galanthamine | NSAIDS | Nivalis
Journal Article
British journal of pharmacology, ISSN 0007-1188, 07/2018, Volume 175, Issue 14, p. 2911
Experimental Approach Based on our data, we conclude that galantamine is not a positive allosteric modulator of [alpha]7 or [alpha]4[beta]2 receptors, which... 
Evaluation | Galanthamine | Alzheimer's disease
Journal Article
Journal Article